Neutrophil Extracellular Traps Enhance Early Inflammatory Response in Sendai Virus-Induced Asthma Phenotype

Antonina Akk1, Luke E Springer1, Christine T N Pham1

  • 1Department of Medicine, Division of Rheumatology, Washington University School of Medicine , Saint Louis, MO , USA.

Frontiers in Immunology
|September 13, 2016
PubMed

Insights

Sendai virus infection triggers neutrophil extracellular traps (NETs) formation, a key driver of asthma development. Inhibiting NETs formation or degrading NETs reduces inflammation, offering potential therapeutic targets for viral-induced asthma.

Area of Science:

  • Immunology
  • Respiratory Medicine
  • Virology

Background:

  • Childhood paramyxoviral infections, like Sendai virus (Sev), are linked to increased asthma rates.
  • Previous studies showed dipeptidyl peptidase I (DPPI) deficiency reduces Sev-induced lung inflammation and asthma.
  • Neutrophils play a role, but the mechanism of DPPI-sufficient neutrophils in asthma development post-Sev infection is unclear.

Purpose of the Study:

  • To investigate the role of neutrophil extracellular traps (NETs) in Sev-induced asthma.
  • To determine if NET formation is dependent on DPPI.
  • To assess the impact of NET inhibition on Sev-induced lung inflammation and asthma.

Main Methods:

  • Sev infection in mice model.
  • Assessment of NET formation using cell-free DNA and myeloperoxidase.
  • In vivo and in vitro studies using DPPI-deficient mice.
  • Administration of DNase 1 or PAD4 inhibitor.
  • Analysis of inflammatory markers and cytokine release.

Main Results:

  • Sev infection induced NET formation in the lungs, peaking at day 2 post-infection.
  • DPPI deficiency significantly reduced Sev-induced NET formation.
  • DNase 1 treatment or PAD4 inhibition suppressed early inflammatory responses to Sev.
  • NETs primed bone marrow-derived cells to release inflammatory cytokines.

Conclusions:

  • NET formation is a critical mechanism linking Sev infection to asthma development.
  • DPPI is essential for Sev-induced NET formation.
  • Targeting NETs formation or degradation may be a therapeutic strategy for viral-induced asthma.

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.6K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K